Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Juan Carlos Plana, Maurizio Galderisi, Ana Barac, et al.
Journal of the American Society of Echocardiography (2014) Vol. 27, Iss. 9, pp. 911-939
Open Access | Times Cited: 1660

Showing 1-25 of 1660 citing articles:

2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo Piepoli, Arno W. Hoes, Stefan Agewall, et al.
European Heart Journal (2016) Vol. 37, Iss. 29, pp. 2315-2381
Open Access | Times Cited: 5964
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, et al.
European Heart Journal (2016) Vol. 37, Iss. 36, pp. 2768-2801
Open Access | Times Cited: 2237
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz, et al.
European Journal of Heart Failure (2016) Vol. 19, Iss. 1, pp. 9-42
Open Access | Times Cited: 1722
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
William J. Gradishar, Benjamin O. Anderson, Ronald Balassanian, et al.
Journal of the National Comprehensive Cancer Network (2018) Vol. 16, Iss. 3, pp. 310-320
Open Access | Times Cited: 1597
Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
Saro H. Armenian, Christina Lacchetti, Ana Barac, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 8, pp. 893-911
Closed Access | Times Cited: 1054
Imaging biomarker roadmap for cancer studies
James P.B. O’Connor, Eric O. Aboagye, Judith E. Adams, et al.
Nature Reviews Clinical Oncology (2016) Vol. 14, Iss. 3, pp. 169-186
Open Access | Times Cited: 940
Management of cardiac disease in cancer patients throughout oncological treatment: ESMO consensus recommendations
Giuseppe Curigliano, Daniel J. Lenihan, Michael G. Fradley, et al.
Annals of Oncology (2020) Vol. 31, Iss. 2, pp. 171-190
Open Access | Times Cited: 807
Myocardial strain imaging: how useful is it in clinical decision making?
Otto A. Smiseth, Hans Torp, Anders Opdahl, et al.
European Heart Journal (2015) Vol. 37, Iss. 15, pp. 1196-1207
Open Access | Times Cited: 752
Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association
Biykem Bozkurt, Monica Colvin, Jennifer Cook, et al.
Circulation (2016) Vol. 134, Iss. 23
Open Access | Times Cited: 695
Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association
Laxmi S. Mehta, Karol E. Watson, Ana Barac, et al.
Circulation (2018) Vol. 137, Iss. 8
Open Access | Times Cited: 675
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Giuseppe Curigliano, Daniela Cardinale, Susan Dent, et al.
CA A Cancer Journal for Clinicians (2016) Vol. 66, Iss. 4, pp. 309-325
Open Access | Times Cited: 654
Standardization of adult transthoracic echocardiography reporting in agreement with recent chamber quantification, diastolic function, and heart valve disease recommendations: an expert consensus document of the European Association of Cardiovascular Imaging
Maurizio Galderisi, Bernard Cosyns, Thor Edvardsen, et al.
European Heart Journal - Cardiovascular Imaging (2017) Vol. 18, Iss. 12, pp. 1301-1310
Open Access | Times Cited: 647
Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
Geeta Gulati, Siri Lagethon Heck, Anne Hansen Ree, et al.
European Heart Journal (2016) Vol. 37, Iss. 21, pp. 1671-1680
Open Access | Times Cited: 574
Assessment of Left Ventricular Function by Echocardiography
Elizabeth Potter, Thomas H. Marwick
JACC. Cardiovascular imaging (2018) Vol. 11, Iss. 2, pp. 260-274
Closed Access | Times Cited: 570
Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio‐Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio‐Oncology Society
Alexander R. Lyon, Susan Dent, Susannah Stanway, et al.
European Journal of Heart Failure (2020) Vol. 22, Iss. 11, pp. 1945-1960
Open Access | Times Cited: 539
Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia
Joerg Herrmann
Nature Reviews Cardiology (2020) Vol. 17, Iss. 8, pp. 474-502
Open Access | Times Cited: 514
A Test in Context: Myocardial Strain Measured by Speckle-Tracking Echocardiography
Patrick Collier, Dermot Phelan, Allan L. Klein
Journal of the American College of Cardiology (2017) Vol. 69, Iss. 8, pp. 1043-1056
Open Access | Times Cited: 475
Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention
Peter Henriksen
Heart (2017) Vol. 104, Iss. 12, pp. 971-977
Closed Access | Times Cited: 458
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo Piepoli, Arno W. Hoes, Stefan Agewall, et al.
Atherosclerosis (2016) Vol. 252, pp. 207-274
Open Access | Times Cited: 451
Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement
Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian, et al.
European Heart Journal (2021) Vol. 43, Iss. 4, pp. 280-299
Open Access | Times Cited: 393
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 2018
J. Atherton, Andrew Sindone, Carmine G. De Pasquale, et al.
Heart Lung and Circulation (2018) Vol. 27, Iss. 10, pp. 1123-1208
Open Access | Times Cited: 362
Cardiotoxicity of anticancer treatments
Michael S. Ewer, Steven M. Ewer
Nature Reviews Cardiology (2015) Vol. 12, Iss. 9, pp. 547-558
Closed Access | Times Cited: 357
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
Edith Pituskin, John R. Mackey, Sheri L. Koshman, et al.
Journal of Clinical Oncology (2017) Vol. 35, Iss. 8, pp. 870-877
Closed Access | Times Cited: 352
Cardiovascular Complications of Cancer Therapy
Hui‐Ming Chang, Rohit Moudgil, Tiziano M. Scarabelli, et al.
Journal of the American College of Cardiology (2017) Vol. 70, Iss. 20, pp. 2536-2551
Open Access | Times Cited: 340
2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology
Russian Journal of Cardiology (2020) Vol. 25, Iss. 11, pp. 4083-4083
Open Access | Times Cited: 335
Page 1 - Next Page

Scroll to top